EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSBTAG00000014972
Gene Symbol: PTGER4
8 Enzyme and pathways 5 Cross references
287 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSBTAG00000015902
Gene Symbol: PTGFR
8 Enzyme and pathways 5 Cross references
207 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSBTAG00000014585
Gene Symbol: PTGIR
11 Enzyme and pathways 5 Cross references
200 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSBTAG00000006716
Gene Symbol: PTGS1
8 Enzyme and pathways 5 Cross references
268 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSBTAG00000014127
Gene Symbol: PTGS2
15 Enzyme and pathways 5 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSBTAG00000006564
Gene Symbol: PSMA1
119 Enzyme and pathways 5 Cross references
248 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSBTAG00000000990
Gene Symbol: PSMA2
120 Enzyme and pathways 5 Cross references
230 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSBTAG00000002808
Gene Symbol: PSMA3
119 Enzyme and pathways 5 Cross references
259 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSBTAG00000014440
Gene Symbol: PSMA4
119 Enzyme and pathways 5 Cross references
261 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSBTAG00000020641
Gene Symbol: PSMA5
120 Enzyme and pathways 5 Cross references
223 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSBTAG00000009683
Gene Symbol: PSMA6
119 Enzyme and pathways 5 Cross references
278 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSBTAG00000005127
Gene Symbol: PSMA7
119 Enzyme and pathways 5 Cross references
161 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).